Delivery Order SPE2DB20D2002-SPE2DB25FL58H
- Not listed
- The Defense Logistics Agency awarded a $2,852.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors (0.5 ml units). The order is scheduled for completion by July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,504.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pen injectors on July 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,356.84 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This contract represents a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency awarded a $5,762.58 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $2,702.70. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, issued on July 18, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,006.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen injectors on July 22, 2025. This non-set-aside competitive award will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a comprehensive pharmaceutical...
- The Defense Logistics Agency awarded a $12,054.36 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,543.18 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The award carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,228.06 by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which is not set-aside and carries an ultimate completion date of July 24, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL58HDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global pharmaceutical supply needs for military healthcare programs. The delivery order will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards covering diverse pharmaceutical products and medical supplies, including diabetes medications, specialty treatments, and medical devices. This delivery order represents a routine transaction within AmerisourceBergen's established relationship with DLA, demonstrating the company's capability to meet federal procurement requirements for essential pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/21/25 |